NCT06550271View on ClinicalTrials.gov

The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals

CompletedOBSERVATIONAL

Enrollment

67

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions

Aging

Interventions

DRUG

Rapamycin

Rapamycin in 2 different dosage forms (compounded and generic)

Trial Locations (1)

48104

AgelessRx, Ann Arbor

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AgelessRx

INDUSTRY